Búsqueda | Portal de Búsqueda de la BVS España

1.

Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Maxwell, Jessica E; Naraev, Boris; Halperin, Daniel M; Choti, Michael A; Halfdanarson, Thorvardur R.

Ann Surg Oncol; 29(5): 3072-3084, 2022 May.

Artículo en Inglés | MEDLINE | ID: mdl-35165817

2.

Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors.

Naraev, Boris G; Mailman, Josh; Halfdanarson, Thorvardur R; Soares, Heloisa P; Mittra, Erik S; Hallet, Julie.

Expert Rev Anticancer Ther; 23(6): 601-615, 2023 06.

Artículo en Inglés | MEDLINE | ID: mdl-37158050

3.

Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors.

Naraev, Boris G; Strosberg, Jonathan R; Halfdanarson, Thorvardur R.

Oncology; 83(3): 117-27, 2012.

Artículo en Inglés | MEDLINE | ID: mdl-22797357

4.

Skeletal metastases in advanced pancreatic ductal adenocarcinoma: a retrospective analysis.

Puri, Akshjot; Chang, John; Tanner, Natalee; Lucente, Patricia; Desiongco, Janice; Dragovich, Tomislav; Naraev, Boris; Kundranda, Madappa.

J Gastrointest Oncol; 12(2): 455-463, 2021 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-34012639

5.

Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.

Eads, Jennifer R; Reidy-Lagunes, Diane; Soares, Heloisa P; Chan, Jennifer A; Anthony, Lowell B; Halfdanarson, Thorvardur R; Naraev, Boris G; Wolin, Edward M; Halperin, Daniel M; Li, Daneng; Pommier, Rodney F; Zacks, Jerome S; Morse, Michael A; Metz, David C.

Pancreas; 49(9): 1123-1130, 2020 10.

Artículo en Inglés | MEDLINE | ID: mdl-32991344

6.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.

Halfdanarson, Thorvardur R; Strosberg, Jonathan R; Tang, Laura; Bellizzi, Andrew M; Bergsland, Emily K; O'Dorisio, Thomas M; Halperin, Daniel M; Fishbein, Lauren; Eads, Jennifer; Hope, Thomas A; Singh, Simron; Salem, Riad; Metz, David C; Naraev, Boris G; Reidy-Lagunes, Diane L; Howe, James R; Pommier, Rodney F; Menda, Yusuf; Chan, Jennifer A.

Pancreas; 49(7): 863-881, 2020 08.

Artículo en Inglés | MEDLINE | ID: mdl-32675783

7.

Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.

Naraev, Boris G; Ramirez, Robert A; Kendi, A Tuba; Halfdanarson, Thorvardur R.

Clin Lung Cancer; 20(3): e376-e392, 2019 05.

Artículo en Inglés | MEDLINE | ID: mdl-30910575

8.

Management of Diarrhea in Patients With Carcinoid Syndrome.

Naraev, Boris G; Halland, Magnus; Halperin, Daniel M; Purvis, Amy J; OÊ¼Dorisio, Thomas M; Halfdanarson, Thorvardur R.

Pancreas; 48(8): 961-972, 2019 09.

Artículo en Inglés | MEDLINE | ID: mdl-31425482

9.

Traumatic neuroma of the tympanic (Jacobson's) nerve as a possible cause of otalgia.

Naraev, Boris G; Linthicum, Fred H.

Otolaryngol Head Neck Surg; 138(6): 735-7, 2008 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-18503845

10.

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Ramage, John; Naraev, Boris G; Halfdanarson, Thorvardur R.

Semin Oncol; 45(4): 236-248, 2018 08.

Artículo en Inglés | MEDLINE | ID: mdl-30539715

11.

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.

Kakadia, Sunilkumar; Yarlagadda, Naveen; Awad, Ramez; Kundranda, Madappa; Niu, Jiaxin; Naraev, Boris; Mina, Lida; Dragovich, Tomislav; Gimbel, Mark; Mahmoud, Fade.

Onco Targets Ther; 11: 7095-7107, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30410366

12.

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.

Sharma, Nancy; Naraev, Boris G; Engelman, Eric G; Zimmerman, M Bridget; Bushnell, David L; OÊ¼Dorisio, Thomas M; OÊ¼Dorisio, M Sue; Menda, Yusuf; Müller-Brand, Jan; Howe, James R; Halfdanarson, Thorvardur R.

Pancreas; 46(2): 151-156, 2017 02.

Artículo en Inglés | MEDLINE | ID: mdl-27759712

13.

Patient Travel Concerns After Treatment with ¹⁷⁷Lu-DOTATATE.

Kendi, Ayse Tuba; Mailman, Josh A; Naraev, Boris G; Mercer, David J; Underwood, James K; Halfdanarson, Thorvardur R.

J Nucl Med; 61(4): 496-497, 2020 04.

Artículo en Inglés | MEDLINE | ID: mdl-32169915

14.

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.

Engelman, Eric S; Leon-Ferre, Roberto; Naraev, Boris G; Sharma, Nancy; Sun, Shiliang; O'Dorisio, Thomas M; Howe, James; Button, Anna; Zamba, Gideon; Halfdanarson, Thorvardur R.

Pancreas; 43(2): 219-25, 2014 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-24518499

15.

Rapid hearing loss in chronic lymphocytic leukemia.

Naraev, Boris G; Linthicum, Fred H.

Otol Neurotol; 27(3): 445-6, 2006 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-16639289

16.

Temporal bone involvement in multiple myeloma.

Naraev, Boris G; Linthicum, Fred H.

Otol Neurotol; 27(4): 580-1, 2006 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-16691154

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Shifting Paradigms in the Pathophysiology and Treatment of Carcinoid Crisis.

Consideration of quality of life in the treatment decision-making for patients with advanced gastroenteropancreatic neuroendocrine tumors.

Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors.

Skeletal metastases in advanced pancreatic ductal adenocarcinoma: a retrospective analysis.

Differential Diagnosis of Diarrhea in Patients With Neuroendocrine Tumors.

The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Pancreatic Neuroendocrine Tumors.

Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.

Management of Diarrhea in Patients With Carcinoid Syndrome.

Traumatic neuroma of the tympanic (Jacobson's) nerve as a possible cause of otalgia.

Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors.

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.

Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors.

Patient Travel Concerns After Treatment with ¹⁷⁷Lu-DOTATATE.

Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.

Rapid hearing loss in chronic lymphocytic leukemia.

Temporal bone involvement in multiple myeloma.